[go: up one dir, main page]

DK2405893T3 - Præparat på oliebasis indeholdende anti-protozoiske triaziner og anthelmintiske cyclodepsipeptider - Google Patents

Præparat på oliebasis indeholdende anti-protozoiske triaziner og anthelmintiske cyclodepsipeptider Download PDF

Info

Publication number
DK2405893T3
DK2405893T3 DK10707228.2T DK10707228T DK2405893T3 DK 2405893 T3 DK2405893 T3 DK 2405893T3 DK 10707228 T DK10707228 T DK 10707228T DK 2405893 T3 DK2405893 T3 DK 2405893T3
Authority
DK
Denmark
Prior art keywords
spp
weight
toltrazuril
emodepside
agent
Prior art date
Application number
DK10707228.2T
Other languages
English (en)
Inventor
Venkata-Rangarao Kanikanti
Achim Harder
Thomas Bach
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Application granted granted Critical
Publication of DK2405893T3 publication Critical patent/DK2405893T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)

Claims (12)

1. Midler indeholdende triazin, som er virksom mod parasitiske protozoer, med en kornstørrelse d(90) < 15 ym og et anthelmintisk cyclodepsipeptid i en oliebasis.
2. Middel ifølge krav 1, hvori triazinen er en forbindelse med formlerne (I) eller (II)
(D eller
(Π), hvor R1 står for R3-SC>2- eller R3-S-, R2 står for alkyl, alkoxy, halogen eller SC>2N(CH3)2, og R3 står for halogenalkyl, R4 og R5 uafhængigt af hinanden står for hydrogen eller Cl, og R6 står for fluor eller chlor samt deres fysiologisk forligelige salte.
3. Middel ifølge et af de foregående krav, hvori triazinen er toltrazuril, ponazuril eller diclazuril.
4. Middel ifølge et af de foregående krav, hvori det cykliske depsipeptid er et 24-leddet octacyclodepsipeptid.
5. Middel ifølge krav 4, hvori det cykliske depsipeptid er emodepsid.
6. Middel ifølge krav 4, hvori det cykliske depsipeptid er PF 1022.
7. Middel ifølge et af de foregående krav indeholdende et fortykningsmiddel, navnlig en glycerolester.
8. Middel ifølge krav 7 indeholdende en glyceroldiester med C12-C24-fedtsyrer som fortykningsmiddel.
9. Middel ifølge krav 8 indeholdende glyceroldibehenat som fortykningsmiddel.
10. Middel ifølge krav 9 indeholdende: 2-4 vægt-% toltrazuril 0,1 - 0,2 vægt-% emodepsid 2-5 vægt-% glyceryldibehenat 0,05 - 0,5 vægt-% butylhydroxytoluen 0,02 - 0,1 vægt-% sorbinsyre ad 100 vægt-% solsikkeolie
11. Anvendelse af midler ifølge et af de foregående krav til fremstilling af lægemidler til bekæmpelse af parasitære protozoer og endoparasitter hos mennesker og dyr.
12. Middel ifølge et af de foregående krav til bekæmpelse af parasitære protozoer og endoparasitter hos dyr.
DK10707228.2T 2009-03-10 2010-03-05 Præparat på oliebasis indeholdende anti-protozoiske triaziner og anthelmintiske cyclodepsipeptider DK2405893T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009012423A DE102009012423A1 (de) 2009-03-10 2009-03-10 Zubereitung auf Ölbasis
PCT/EP2010/001396 WO2010102762A1 (de) 2009-03-10 2010-03-05 Zubereitung auf ölbasis enthaltend anti-protozoische triazine und anthelmintische cyclodepsipeptide

Publications (1)

Publication Number Publication Date
DK2405893T3 true DK2405893T3 (da) 2015-07-27

Family

ID=42105958

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10707228.2T DK2405893T3 (da) 2009-03-10 2010-03-05 Præparat på oliebasis indeholdende anti-protozoiske triaziner og anthelmintiske cyclodepsipeptider

Country Status (21)

Country Link
US (1) US20120141546A1 (da)
EP (1) EP2405893B1 (da)
JP (2) JP5845092B2 (da)
KR (1) KR101779618B1 (da)
CN (2) CN102348454A (da)
AR (1) AR075629A1 (da)
AU (1) AU2010223539B2 (da)
BR (1) BRPI1009434A2 (da)
CA (1) CA2754623C (da)
DE (1) DE102009012423A1 (da)
DK (1) DK2405893T3 (da)
ES (1) ES2542552T3 (da)
HR (1) HRP20150780T1 (da)
MX (1) MX2011009113A (da)
NZ (1) NZ595050A (da)
PL (1) PL2405893T3 (da)
PT (1) PT2405893E (da)
SI (1) SI2405893T1 (da)
TW (1) TW201043234A (da)
WO (1) WO2010102762A1 (da)
ZA (1) ZA201106349B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX368209B (es) 2011-12-21 2019-09-24 Bayer Pharma Ag Star Preparaciones que comprenden emodepsido amorfo.
CN110292561A (zh) * 2019-07-12 2019-10-01 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 一种具有抗球虫作用的口服药物溶液配方及制备
EP3888684A1 (en) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (de) * 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
JPH0570366A (ja) * 1991-03-08 1993-03-23 Meiji Seika Kaisha Ltd 薬用組成物
WO1993019053A1 (en) 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
AU695021B2 (en) 1993-02-19 1998-08-06 Meiji Seika Kaisha Ltd. PF1022 derivative cyclic depsipeptide
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
BR9407711A (pt) 1993-09-06 1997-02-12 Fujisawa Pharmaceutical Co Composto de ciclopeptídeo processo para preparaçao de um composto de ciclopeptídeo e parasiticida
DE4342907A1 (de) 1993-12-16 1995-06-22 Bayer Ag Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
DE4400464A1 (de) 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4401389A1 (de) 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
DE4412492A1 (de) 1994-04-12 1995-10-19 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen
DE4437198A1 (de) 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
US5856436A (en) 1995-06-30 1999-01-05 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, process for production thereof, and novel intermediate therefor
HU228004B1 (en) 1995-09-22 2012-08-28 Bayer Animal Health Gmbh Cyclic depsipeptide pf1022 derivatives
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
DE19545639A1 (de) 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
WO1998037088A1 (en) 1997-02-19 1998-08-27 Meiji Seika Kaisha Ltd. Derivatives of cyclodepsipeptide, pf1022 substance
DE19713626A1 (de) 1997-04-02 1998-10-08 Bayer Ag Neue Thiodepsipeptide zur Bekämpfung von Endoparasiten und ein einfaches Verfahren zu ihrer Herstellung
BR9810412A (pt) 1997-06-04 2000-08-22 Bayer Ag Desoxiciclodepsipeptìdios e seu emprego para o combate de endoparasitas
DE19811559A1 (de) 1998-03-17 1999-09-23 Bayer Ag Cyclooctadepsipeptide
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
DE19828047A1 (de) 1998-06-24 1999-12-30 Bayer Ag Substituierte Cyclooctadepsipeptide
DE19840320A1 (de) 1998-09-04 2000-03-09 Bayer Ag Aza-Cyclodepsipeptide
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6194408B1 (en) 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
KR20010080571A (ko) * 1998-12-22 2001-08-22 조지 제이. 리코스 사르코시스티스, 네오스포라 및 톡소플라즈마에 의한 질병치료용 트리아진온 화합물
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
DE19962147A1 (de) * 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE10359798A1 (de) * 2003-12-19 2005-07-21 Bayer Healthcare Ag Cyclohexadepsipeptide zur Bekämpfung von Endoparasiten und ein Verfahren zu ihrer Herstellung
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102005000746A1 (de) * 2005-01-05 2006-07-13 Bayer Healthcare Ag Bekämpfung der Histomoniasis
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
CA2661099C (en) * 2006-08-30 2012-01-24 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
PT2155699E (pt) * 2007-05-15 2015-11-12 Merial Inc Compostos de ariloazol-2-il-cianoetilamino, método de fabrico e método de utilização
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung

Also Published As

Publication number Publication date
JP2015212296A (ja) 2015-11-26
ZA201106349B (en) 2012-11-28
TW201043234A (en) 2010-12-16
JP5845092B2 (ja) 2016-01-20
PL2405893T3 (pl) 2015-10-30
CN105749248A (zh) 2016-07-13
NZ595050A (en) 2013-11-29
CA2754623A1 (en) 2010-09-16
AU2010223539A1 (en) 2011-09-22
DE102009012423A1 (de) 2010-09-16
EP2405893B1 (de) 2015-04-22
PT2405893E (pt) 2015-09-01
CN102348454A (zh) 2012-02-08
SI2405893T1 (sl) 2015-08-31
US20120141546A1 (en) 2012-06-07
CA2754623C (en) 2017-04-18
KR101779618B1 (ko) 2017-09-18
HRP20150780T1 (hr) 2015-08-28
BRPI1009434A2 (pt) 2016-03-01
AR075629A1 (es) 2011-04-20
WO2010102762A1 (de) 2010-09-16
ES2542552T3 (es) 2015-08-06
EP2405893A1 (de) 2012-01-18
AU2010223539B2 (en) 2015-06-11
MX2011009113A (es) 2011-09-26
JP2012520244A (ja) 2012-09-06
KR20110126731A (ko) 2011-11-23

Similar Documents

Publication Publication Date Title
CA2222680C (en) Endoparasiticidal agents
US7763583B2 (en) Endoparasiticidal compositions for topical application
EP0662326B1 (de) Endoparasitizide Mittel die Praziquantel und Epsiprantel enthalten
DK2405893T3 (da) Præparat på oliebasis indeholdende anti-protozoiske triaziner og anthelmintiske cyclodepsipeptider
DE102008030764A1 (de) Kombination von Amidin-Derivaten mit cyclischen Depsipeptiden
ES2233805T3 (es) Modifcacion cristalina de un depsipetido ciclico con avtividad mejorada.
IL150988A (en) Preparations against internal parasites
HUP0201201A2 (en) Endoparasiticidal agents
HUP0102476A2 (hu) Szubsztituált ciklooktadepszipeptidek
DE10131149A1 (de) Substituierte Benzinmidazole zur Bekämpfung von Endoparasiten